Avsnitt Oral immunomodulating therapies in relapsing MS The Lancet Neurology in conversation with Spela Dela Facebook Twitter Kopiera länk
Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis. Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv Rss Apple Podcaster →